Literature DB >> 8054918

Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis.

E Pracher1, E R Panzer-Grümayer, A Zoubek, C Peters, H Gadner.   

Abstract

We report a 5.9-year-old boy with X-linked lymphoproliferative syndrome (XLP) who presented with acute severe infectious mononucleosis. Clinical symptoms rapidly improved after chemotherapy with etoposide. Allogeneic bone marrow transplantation (BMT) was performed after conditioning with etoposide, busulfan and cyclophosphamide. After successful hematopoietic recovery we were able to demonstrate seroconversion from an impaired antibody response to Epstein-Barr virus (EBV) to a normal antibody-producing state in an immunocompetent child. The only post-transplant complication was mild acute graft-versus-host disease (GVHD). Three years after BMT, the boy is healthy and shows no signs of immunodeficiency. This is the first report on successful allogeneic BMT in the severe course of acute infectious mononucleosis in a patient with XLP. We speculate that the application of etoposide contributed to the positive outcome in this patient.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054918

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

Review 1.  X-linked lymphoproliferative syndrome.

Authors:  D L Nelson; C Terhorst
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

Review 2.  X-linked lymphoproliferative disease: genetic lesions and clinical consequences.

Authors:  Andrew J MacGinnitie; Raif Geha
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.806

3.  Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency.

Authors:  Asghar Aghamohammadi; Hirokazu Kanegane; Mostafa Moein; Abolhasan Farhoudi; Zahra Pourpak; Masoud Movahedi; Mohammad Gharagozlou; Ali Akabar Amir Zargar; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

4.  X linked lymphoproliferative disease in a United Kingdom family.

Authors:  P D Arkwright; G Makin; A M Will; M Ayres; D A Gokhale; W D Fergusson; G M Taylor
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

5.  Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease.

Authors:  Boris Hügle; Itziar Astigarraga; Jan-Inge Henter; Anna Porwit-MacDonald; Alfons Meindl; Volker Schuster
Journal:  Eur J Pediatr       Date:  2006-10-21       Impact factor: 3.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.